Transaction #32436 · Form 4 · 0001384133-26-000004
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. · Exercise / conversion · Common Stock
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. · Transacted October 6, 2026 · Filed October 8, 2026
What does this filing report?
An SEC Form 4 filing for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. records an exercise / conversion involving Common Stock on October 6, 2026. The reported quantity was 500,000. The filing date is October 8, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company CIK
- 0001299130
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 500,000
- Reported price
- 1.18
- Reference value
- 590,000
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 1,745,663
- Ownership description
- Not reported
- SEC acceptance time
- Oct 8, 2026, 4:07 PM EDT
- 10b5-1 indication
- Indicated in filing
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Gibson James R II ↗
See Remarks
CIK 0001384133
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2026.
- F2
- This sale price represents the weighted average sale price of the shares sold ranging from $3.00 to $3.33 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- F3
- 1/4th of the shares subject to the option vested on the one year anniversary of the date of grant, and the balance of shares vest monthly thereafter over the next three years, provided that the Reporting Person continues to serve through each vesting date.
Remarks
Chief Financial Officer
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.